Beat it

Beat it

Diabetes Drugs May Carry Risk


Diabetes patients who take drugs called sulfonylureas as an initial therapy have a higher risk of death than those who take the diabetes drug metformin, a new study says.The British researchers said the findings suggest that it may no longer be appropriate to offer sulfonylureas as a first-line treatment.




Both metformin (brand names include Glucophage and Fortamet) and sulfonylureas (glyburide and glipizide) are commonly prescribed as first-line therapies for patients and have been available since the 1950s.